penicillamine has been researched along with Itching in 16 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alclofenac and D-penicillamine were compared under controlled, double-blind conditions in the treatment of 35 patients with active rheumatoid arthritis over a period of 26 weeks." | 9.04 | The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. ( Aylward, M; Holly, F; Maddock, J; Rees, P, 1975) |
| "Doses of 600 mg and 1200 mg of D(-)penicillamine daily were superior to a standard regimen of therapy in rheumatoid arthritis." | 9.04 | Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. ( Davies, J; Dixon, AJ; Dormandy, TL; Hamilton, EB; Holt, PJ; Mason, RM; Thompson, M; Weber, JC; Zutshi, DW, 1975) |
| "Twenty-three patients with the chronic progressive or intermittent relapsing form of multiple sclerosis (MS) were treated with d-penicillamine over a period from 6 weeks to 12 months." | 9.04 | Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study. ( Cendrowski, W; Czlonkowska, A, 1976) |
| "Alclofenac and D-penicillamine were compared under controlled, double-blind conditions in the treatment of 35 patients with active rheumatoid arthritis over a period of 26 weeks." | 5.04 | The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. ( Aylward, M; Holly, F; Maddock, J; Rees, P, 1975) |
| "Doses of 600 mg and 1200 mg of D(-)penicillamine daily were superior to a standard regimen of therapy in rheumatoid arthritis." | 5.04 | Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. ( Davies, J; Dixon, AJ; Dormandy, TL; Hamilton, EB; Holt, PJ; Mason, RM; Thompson, M; Weber, JC; Zutshi, DW, 1975) |
| "Twenty-three patients with the chronic progressive or intermittent relapsing form of multiple sclerosis (MS) were treated with d-penicillamine over a period from 6 weeks to 12 months." | 5.04 | Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study. ( Cendrowski, W; Czlonkowska, A, 1976) |
| " Over a 2-yr period we have prospectively reviewed 114 patients with a suspected adverse cutaneous reaction to anti-rheumatic drugs." | 1.29 | Suspected cutaneous drug toxicity in rheumatoid arthritis--an evaluation. ( Davis, MJ; Dawes, PT; Mattey, DL; Smith, AG; Wilkinson, SM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Liang, J | 1 |
| Xu, J | 1 |
| Chen, L | 1 |
| MCDONALD, JE | 1 |
| HENNEMAN, PH | 1 |
| Bailin, PL | 1 |
| Matkaluk, RM | 1 |
| Evans, J | 1 |
| Zerpa, H | 1 |
| Nuttall, L | 1 |
| Boss, M | 1 |
| Sherlock, S | 1 |
| Rosen, R | 1 |
| Theodor, E | 1 |
| Wilkinson, SM | 1 |
| Smith, AG | 1 |
| Davis, MJ | 1 |
| Mattey, DL | 1 |
| Dawes, PT | 1 |
| Maddock, J | 1 |
| Rees, P | 1 |
| Holly, F | 1 |
| Aylward, M | 1 |
| Dickson, ER | 1 |
| Fleming, CR | 1 |
| Ludwig, J | 1 |
| Delcambre, B | 1 |
| Bergoend, H | 1 |
| Defrance, D | 1 |
| Piette, F | 1 |
| Duquesnoy, B | 1 |
| Carlier, D | 1 |
| Van Tichelen, P | 1 |
| Trnavský, K | 1 |
| Zbojanová, M | 1 |
| van Berge Henegouwen, GP | 1 |
| Brandt, KH | 1 |
| Schalm, SW | 1 |
| Dixon, AJ | 1 |
| Davies, J | 1 |
| Dormandy, TL | 1 |
| Hamilton, EB | 1 |
| Holt, PJ | 1 |
| Mason, RM | 1 |
| Thompson, M | 1 |
| Weber, JC | 1 |
| Zutshi, DW | 1 |
| Cendrowski, W | 1 |
| Czlonkowska, A | 1 |
| Adams, D | 1 |
| Clements, D | 1 |
| Elias, E | 1 |
| Warnes, TW | 1 |
| Civatte, J | 1 |
| Belaich, S | 1 |
| Blanchet, P | 1 |
5 reviews available for penicillamine and Itching
| Article | Year |
|---|---|
Cutaneous reactions to rheumatological drugs.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cushing Syndrome; Cy | 1982 |
Primary biliary cirrhosis.
Topics: Adult; Aged; Antigen-Antibody Complex; Copper; Esophageal and Gastric Varices; Female; Humans; Liver | 1979 |
The treatment of primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Antipruritics; Azathioprine; Celiac Disease; Chlorambucil; Colchicine; Cycl | 1986 |
Treatment of primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chlorambucil; Cholelithiasis; Colchicine | 1985 |
[Dermatology from 1969 to 1973].
Topics: Agammaglobulinemia; Blood Protein Disorders; Bromides; Candidiasis, Cutaneous; Carcinoid Tumor; Derm | 1974 |
3 trials available for penicillamine and Itching
| Article | Year |
|---|---|
The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Clinical Trials as T | 1975 |
Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Dyspepsia; Female; Humans; | 1975 |
Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study.
Topics: Adult; Ageusia; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Dyspepsia; Erythema; Fem | 1976 |
8 other studies available for penicillamine and Itching
| Article | Year |
|---|---|
Effective treatment of d-penicillamine induced elastosis perforans serpiginosa with ALA-PDT.
Topics: Adult; Aminolevulinic Acid; Chelating Agents; Humans; Male; Penicillamine; Photochemotherapy; Photos | 2015 |
STONE DISSOLUTION IN VIVO AND CONTROL OF CYSTINURIA WITH D-PENICILLAMINE.
Topics: Alkaline Phosphatase; Blood Sedimentation; Cystinuria; Drug Therapy; Eosinophilia; Humans; Kidney Ca | 1965 |
Copper chelation therapy in intrahepatic cholestasis of childhood.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholestasis, Intrahepatic; Copper; Ethylenediamines; Fem | 1983 |
[Primary biliary cirrhosis].
Topics: Adrenal Cortex Hormones; Adult; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; | 1982 |
Suspected cutaneous drug toxicity in rheumatoid arthritis--an evaluation.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, | 1993 |
[Pemphigus caused by D-penicillamine during treatment of rheumatoid arthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Pemphigus; Penicillamine; Pru | 1979 |
[Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
Topics: Ageusia; Arthritis, Rheumatoid; Humans; Kidney Diseases; Myasthenia Gravis; Penicillamine; Proteinur | 1979 |
[Current insights in the treatment of primary biliary cirrhosis].
Topics: Azathioprine; Copper; Humans; Liver Cirrhosis, Biliary; Osteomalacia; Penicillamine; Pruritus; Vitam | 1978 |